Jane Street Group, LLC Kura Oncology, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	BUY	$12.22 - $19.57 $13,442 - $21,527	1,100 Added 8.94%	13,400 $188,000
Q3 2021 Nov 16, 2021	SELL	$15.42 - $21.72 $442,554 - $623,364	-28,700 Reduced 70.0%	12,300 $230,000
Q4 2020 Feb 17, 2021	SELL	$29.0 - $41.62 $1.02 Million - $1.46 Million	-35,000 Reduced 46.05%	41,000 $1.34 Million
Q3 2020 Nov 17, 2020	BUY	$16.3 - $30.64 $1.24 Million - $2.33 Million	76,000 New	76,000 $2.33 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $722M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.